ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Grants Accelerated Approval To Ferriprox for Iron Overload

October 28, 2011

Clinical Trials Approved By NCI Listed For September

September 24, 2004

Breast Cancer Task Force to Issue New RFPs In July, September

July 9, 1976

FCRF Program Proving Good Basic Research Can Be Supported By NCI With a Contract

January 23, 1987

How NCI Plans to Spend the $3 Billion Budget; But First, A Caveat From the Director

November 19, 1999

McDonald’s Charity Commits $5 Million To Pediatric Research

May 17, 1991